NCT01736709View on ClinicalTrials.gov

The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

May 31, 2013

Conditions
Influenza
Interventions
BIOLOGICAL

2012-2013 trivalent seasonal influenza vaccine

trivalent seasonal influenza vaccine with 0.25 ml ⁄ vial, for infants trivalent seasonal influenza vaccine with 0.5 ml ⁄ vial, for adults and old people

Trial Locations (1)

Unknown

Henan Center for Diseases Control and Prevention, Zhengzhou

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT01736709 - The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine | Biotech Hunter | Biotech Hunter